Reaching Clinical Trial Excellence

Join us for Reaching Clinical Trial Excellence: Practical Strategies for Achieving Generalizable and Transportable Data, an in-depth program focused on dismantling systemic inequities in cancer clinical research through diversity-focused, actionable frameworks. Developed by Indy Hematology Education (IHE), the DRIVE Initiative aims to establish measurable standards for equitable representation in clinical trials, leadership, authorship, and access.

This symposium convenes oncology professionals, researchers, and policy advocates to explore the current challenges and strategic solutions in advancing inclusive excellence across the cancer research continuum. Attendees will engage with thought leaders discussing policy-aligned models for accountability, tools for building diversity plans into clinical trial design, and methods for standardizing demographic reporting in academic publications.

With a focus on practical implementation, the DRIVE Initiative offers a blueprint to help institutions, sponsors, and investigators align with regulatory guidance, such as the U.S. FDORA Act of 2022, while advocating for its broader international adoption. This is more than an academic discussion; it's a call to action for stakeholders committed to advancing equitable outcomes in cancer care and research.

Host or Publisher Indy Hematology Review